Rockefeller Capital Management L.P. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$656,250
-31.9%
120,413
-21.3%
0.00%
-25.0%
Q2 2023$964,200
+66168.0%
153,081
-7.2%
0.00%
-33.3%
Q1 2023$1,455
+14.5%
164,954
-1.0%
0.01%0.0%
Q4 2022$1,271
-99.9%
166,564
-6.0%
0.01%
-14.3%
Q3 2022$1,260,000
-17.1%
177,113
-5.7%
0.01%
-12.5%
Q2 2022$1,519,000
-41.7%
187,861
-0.0%
0.01%
-38.5%
Q1 2022$2,607,000
-43.8%
187,900
+13.6%
0.01%
-40.9%
Q4 2021$4,639,000
+3.5%
165,368
+25.4%
0.02%
-8.3%
Q3 2021$4,480,000
-14.4%
131,841
+2.9%
0.02%
-17.2%
Q2 2021$5,234,000
-80.9%
128,114
-81.1%
0.03%
-84.3%
Q1 2021$27,356,000
+1037.0%
679,563
+1568.8%
0.18%
+927.8%
Q4 2020$2,406,000
+113.7%
40,722
+75.8%
0.02%
+63.6%
Q3 2020$1,126,000
+169.4%
23,160
+168.1%
0.01%
+175.0%
Q2 2020$418,000
+290.7%
8,640
+125.0%
0.00%
+300.0%
Q1 2020$107,000
+494.4%
3,840
+548.6%
0.00%
Q4 2019$18,000
-40.0%
592
-39.3%
0.00%
Q3 2019$30,0009750.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders